Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Exciting updates in biomarkers of response to neoadjuvant chemotherapy

Christos Sotiriou, MD, PhD, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium, highlights the exciting new findings in biomarker responses to neoadjuvant therapy which will be discussed at the San Antonio Breast Cancer Symposium (SABCS) 2020, including research into blood-based biomarkers and biomarker gene expression profiles. The advantages of neoadjuvant therapy will also be presented, as well as new data further validating previous findings in the field. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).